Affordable generics will stay relevant amid a premiumisation trend: Bhushan Akshikar
GSK Pharmaceuticals India focuses on affordable general medicine access amidst premiumisation trend, discussed by managing ...
EURACTIV19h
Belgium a pharma leader, investing €15.5 million per day in pharmaceutical R&D
Belgium has solidified its position as a European leader in pharmaceutical research and development with a daily investment ...
BioPharma Dive22h
GSK partners with Flagship startup to hunt for Parkinson’s drugs
Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...
Pharmaceutical Technology23h
Are dry powder inhalers the key to sustainable respiratory care?
Though prescribing climate-friendly dry powder inhalers is environmentally sound, some experts warn certain patients may be ...
GlaxoSmithKline (GSK) was downgraded to a Hold Rating at Jefferies
In a report released today, Peter Welford from Jefferies downgraded GlaxoSmithKline (GSK – Research Report) to a Hold, with a price ...